Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.2144 -0.0159 (-6.90%)
Streaming Delayed Price Updated: 1:03 PM EDT, Jul 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Launches Subscription Model
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
Company at a Turning Point — Moving the Business to a Different Level, With Growing Revenue and a Roadmap Toward Improved Profitability 
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM)
Via Get News
Topics Artificial Intelligence Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.